Patent

© Madeleine_Steinbach / Getty Images

Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.

By Stephen Daniells

Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.

© iStock/RawpixelLtd

Scouting out Europe's latest free-from innovation at SIAL

By Niamh Michail

What are the latest free-from trends sweeping Europe? How is the mature gluten-free market staying innovative? And how much on-pack prominence should you give to free-from claims? FoodNavigator hit the expo floor at SIAL in Paris to find out.

© iStock / pilipenkoD

Aker, Neptune reach landmark krill oil licensing agreement

By Hank Schultz

The Thirty Years War that reshaped Europe featured myriad twists and turns. The Krill Wars have, too, with the latest being a final, formal burying of the hatchet between the two principal players, Aker BioMarine and Neptune Technologies and Bioressources.

Nestlé defends plant patenting as 300,000 protest

Nestlé defends plant patenting as 300,000 protest

By Shane STARLING

Nestlé has affirmed its position in the face of an NGO-led petition begun in April that has won 331,500 signatures protesting the food firm's intentions for the nutrient-rich fennel flower.

Neptune's European patent on krill oil revoked

Neptune's European patent on krill oil revoked

By Hank Schultz

The European Patent Office has revoked one of the patents held by krill oil supplier Neptune Technologies & Bioressources.  As has become de rigueur in the IP battle among krill companies, the various players disagree about what the action means.

Neptune and Aker facing off in court yet again

Krill wars

Neptune and Aker facing off in court yet again

By RJ Whitehead

Australia is the site of the latest battle between Neptune and Aker Biomarine. In addition to patent strife between the two krill majors in American courts, Canadian Neptune has now announced that it filed opposition to an Aker patent application earlier...

Neptune secures US patent for krill cardio health benefits

Neptune secures US patent for krill cardio health benefits

By Elaine Watson

Neptune Technologies & Bioressources has bolstered its intellectual property portfolio further after securing a new US patent (No. 8,057,825) awarding it the exclusive use of krill extracts in the US as a method for reducing cholesterol, platelet...

Are health claims doomed?

Are health claims doomed?

With concern about the severity of EFSA’s health claim rulings raging, industry is asking if the regime may be stifling innovation and restricting the market. Shane Starling reports.